HSAN-6

DST | 2012

What Is HSAN-6?

HSAN-6 is a type of CMT caused by autosomal recessive mutations in the DST gene. This gene provides instructions for making dystonin, a cytoskeletal protein that helps maintain the structural integrity of sensory nerve cells. Mutations in the DST gene disrupt this function, leading to impaired nerve signal transmission.

HSAN-6 is autosomal recessive, meaning that both copies of the gene must have a mutation to cause this subtype.

Clinical Features

The age of symptom onset in HSAN-6 is variable, ranging from childhood to adulthood. The disease involves loss of sensation that begins in the hands and feet (glove-and-stocking distribution) and progresses over time towards the center of the body. Nerve conduction studies usually show somewhat slowed conduction velocities and reduced amplitudes, consistent with an axonal form of CMT.

HSAN-6 symptoms may include:

  • Progressive loss of sensation in the feet and hands
  • Loss of pain and temperature sensation
  • Autonomic dysfunction
  • Respiratory and feeding difficulties, particularly in infancy
  • Reduced or absent reflexes
  • Foot deformities, including high arches, and hammertoes (clawed toes)
  • Distal weakness that develops as the disease progresses
  • Foot drop
  • Additional symptoms not listed here

Disease Course

HSAN-6 shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
HSAN-6

Classification
HSAN

Neuropathy Type
Axonal

Inheritance Pattern
autosomal recessive

Genetic Context

HGNC-Approved Gene Symbol
DST

Gene Full Name
Dystonin

Chromosome
6p12.1

Zygosity of Responsible Variant
Homozygous

Variant Mechanism

Loss of Function (LoF)

Details

Mechanistic basis:
Biallelic

Confidence:
Medium

Prediction:
The literature predicts a biallelic loss-of-function mechanism for HSAN-6: recessive DST truncating and null variants abolish dystonin, and the parallel Dst-null (dystonia musculorum) mouse recapitulates the sensory neurodegeneration, so two lost copies remove function while one wild-type copy suffices. Restored wild-type dystonin is predicted to rescue, consistent with loss rather than a dominant-negative effect.

Rationale:
Biallelic DST truncating or null alleles abolish dystonin, so a single wild-type copy should suffice and restored wild-type is predicted to rescue: a recessive loss of function, supported by the Dst-null dystonia musculorum mouse with no gain-of-function contribution.

ClinVar Pathogenic Variants

View HSAN-6 ClinVar Variants

HSAN-6 OMIM Entry

HSAN-6 OMIM

DST OMIM Entry

DST OMIM

More Info

HSAN-6 Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

Hereditary Sensory Autonomic Neuropathy Caused by a Mutation in Dystonin

Authors

Edvardson, S., Cinnamon, Y., Jalas, C., Shaag, A., Maayan, C., Axelrod, F. B., & Elpeleg, O.

Publication Date
January 9, 2012

Updated: July 18, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


Jean-Martin Charcot lecturing at the Salpêtrière while comparing anatomical illustrations of a cavovarus Charcot-Marie-Tooth (CMT) foot and a Charcot neuroarthropathy foot, highlighting two different conditions that share the Charcot name.


A Name That Does Too Much Work

Jean-Martin Charcot's name appears throughout medicine, but nowhere does it create more confusion than in the foot. Learn why the CMT foot and Charcot neuroarthropathy, also known as Charcot foot, share a name yet differ in how they develop, appear, and are managed.


Close-up of a doctor’s hand holding a prescription pad while a patient’s wrist is wrapped with metal chains.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Illustrated graphic showing large ‘404’ numerals with people interacting with data screens and servers, alongside text reading ‘CMT Genetic Testing Error 404: Gene Not Found’ and ‘Examining Why Less Than Half of All Who Have Charcot-Marie-Tooth Disease Are Not Able to Obtain Genetic Confirmation of Their Disease.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.